Home Health Senate Faces Hemp Ban Decision as Congress Resumes

Senate Faces Hemp Ban Decision as Congress Resumes

Senate Faces Hemp Ban Decision as Congress Resumes

As Congress reconvenes following the August recess, attention turns to a crucial funding bill. This legislation contains a provision to extend the ban on most hemp-derived THC products by one month, pushing the prohibition to December 11. Representative Andy Harris (R-Md.), leading the House Freedom Caucus, opposes this delay. He argues that products, often termed ‘gas station weed,’ falsely pose as hemp while essentially being unregulated marijuana. His stance is firm, aiming to end what he sees as regulatory failures.

Harris holds a key position as chairman of the House Agriculture Appropriations Subcommittee. Together with Senator Mitch McConnell (R-Ky.), he played a significant role in last year’s enactment of the ban. However, the White House has influenced the current delay inclusion, seeking to address the hemp issue comprehensively. Although the hemp industry and supporters view this reprieve as a victory providing time to advocate for regulation over prohibition, quick passage met resistance in the Senate earlier this month. Efforts to remove the delay provision fell short, with a Senate vote of 61-32 against an amendment led by Senator Ted Budd (R-N.C.).

Looking ahead, GOP senators hint at potential challenges to maintain the ban in the coming months. The current funding bill extends until December 11, and White House officials seem disinclined to request another postponement.

The healthcare sector is also navigating major developments. Recently, the Food and Drug Administration (FDA) authorized new COVID-19 vaccines. These updated shots, prioritized for higher-risk populations, have been cleared for distribution to pharmacies and healthcare providers. This includes mRNA vaccines from Pfizer-BioNTech and Moderna, as well as a non-mRNA vaccine from Sanofi.

Meanwhile, former Trump administration health figures question the cause of two recent measles-related deaths in Pennsylvania, emphasizing the need for further investigation. Elsewhere, South Carolina’s Senate Democratic nominee, Annie Andrews, dismisses ‘Medicare for All’ as outdated, emphasizing practicality in her approach to healthcare.

On the state level, vaccination rates face challenges as Maryland reports measles outbreaks in three counties. Pennsylvania sees mothers protesting how opioid settlement funds are allocated, and Idaho officials face legal action over potentially misleading ballot language concerning an abortion initiative.

Leave a Reply

Your email address will not be published.